Skip to content
Updated April 2026

Foundayo vs Ozempic

Two daily GLP-1 medications — one is a brand-new pill, one is a decade-old injection. Here’s how the outcomes and cost compare.

11.1%

Avg weight loss Foundayo

15%

Avg weight loss Ozempic

$935/mo

Ozempic retail (no insurance)

$99

Ozempic via telehealth

Overview

What are they?

Ozempic is a once-weekly injectable semaglutide. Foundayo is a daily oral orforglipron pill that can be taken any time without food or water restrictions.

Ozempic is FDA-approved for type 2 diabetes, not for weight loss. Wegovy is the FDA-approved semaglutide formulation for chronic weight management.

Foundayo

Weight Management

FDA-approved oral GLP-1 receptor agonist for chronic weight management — the first weight-loss pill that can be taken at any time of day with no food or water restrictions. Made by Eli Lilly, approved April 2026.

Maker

Eli Lilly

Approved

2026

Format

Daily oral pill

Max dose

17.2 mg

Ozempic

Type 2 Diabetes

FDA-approved to improve blood sugar in adults with type 2 diabetes. Frequently prescribed off-label for weight loss due to its semaglutide formulation.

Maker

Novo Nordisk

Approved

2017

Format

Weekly injection

Max dose

2.0 mg

Side by side

Quick comparison

How they stack up on the metrics that matter most.

Active ingredient

Foundayo

Orforglipron

Ozempic

Semaglutide

FDA approved for

Foundayo

Weight Management

Ozempic

Type 2 diabetes

Max dose

Foundayo

17.2 mg

Ozempic

2.0 mg

Avg weight loss

Foundayo

~11.1%

Ozempic

~15%

Administration

Foundayo

Daily oral pill

Ozempic

Weekly injection

Insurance

Foundayo

Limited

Ozempic

Broader

Retail price/mo

Foundayo

$779/mo

Ozempic

$935/mo

Telehealth price

Foundayo

From $149/mo

Ozempic

From $99/mo

More energy,

less weight

Dosing schedule

How you ramp up

Both medications use a gradual dose escalation to minimize side effects.

Foundayo

  1. 1

    0.8 mg

    Month 1

    (Daily)

  2. 2

    2.5 mg

    Month 2

    (Daily)

  3. 3

    5.5 mg

    Month 3

    (Daily)

  4. 4

    9 mg

    Month 4

    (Daily)

  5. 5

    14.5 mg

    Month 5

    (Daily)

  6. 6

    17.2 mg

    Month 6+

    (Maintenance)

Ozempic

  1. 1

    0.25 mg

    Weeks 1–4

  2. 2

    0.5 mg

    Weeks 5–8

  3. 3

    1.0 mg

    Weeks 9+

    (Maintenance)

  4. 4

    2.0 mg

    Optional max dose

Cost breakdown

What you’ll pay

Real pricing — no misleading teaser rates or hidden fees.

Foundayo

Foundayo

Retail (no insurance)
$779/mo
With insurance
$25–$200/mo
Telehealth (compounded)
From $149/mo
Manufacturer savings
Available

Special offer

Save up to 30% EVERY month!

Best value
Ozempic

Ozempic

Retail (no insurance)
$935/mo
With insurance
$25–$150/mo
Telehealth (compounded)
From $99/mo
Manufacturer savings
Available

Special offer

Save up to 30% EVERY month!

Some providers pay BestGLP1 a referral fee when you sign up. We disclose this because the FTC requires it. Our rankings are editorial.

Start your weight‑loss journey today

Start your weight‑loss

journey today

Real-world results

Weight loss compared

Clinical trial data showing average body weight reduction over 68 weeks.

Foundayo (17.2 mg)

11.1%

Ozempic (2.0 mg)

15%

Placebo

2.4%
Side effects

What to expect

How they stack up on the metrics that matter most.

Nausea

Foundayo

35%

Ozempic

20%

Diarrhea

Foundayo

25%

Ozempic

9%

Vomiting

Foundayo

22%

Ozempic

9%

Constipation

Foundayo

24%

Ozempic

3.1%

Headache

Foundayo

9%

Ozempic

1.6%

Fatigue

Foundayo

9%

Ozempic

2.5%

* Foundayo rates at 17.2 mg max dose

Side effects are generally most pronounced during the first 4–8 weeks and tend to subside. Always consult your healthcare provider.

Our take

The bottom line

Different molecules, different mechanisms. Here’s how to think about it.

Choose based on your goal

  • Choose Ozempic if you have type 2 diabetes, have insurance that covers it, or prefer a weekly injection over daily dosing.
  • Choose Foundayo if you want Foundayo (FDA-approved for chronic weight management) with no injection anxiety and no food or timing restrictions.

Some providers pay BestGLP1 a referral fee when you sign up. We disclose this because the FTC requires it. Our rankings are editorial.

Common questions

What you
need to know

In trials, Foundayo (orforglipron) produced about 11.1% average weight loss compared with Ozempic’s 15% over 68 weeks. Ozempic still leads on raw outcomes, but Foundayo is competitive for an oral option and avoids injections entirely.

Foundayo is FDA-approved for chronic weight management, not type 2 diabetes. If diabetes is your primary concern, Ozempic or another GLP-1 with a diabetes indication is usually the better fit — talk to your provider about which approval matches your diagnosis.

Oral orforglipron is taken every day with no food or water restrictions, while Ozempic is a once-weekly self-injection. Pills are typically easier for needle-averse patients, but weekly dosing means fewer total decisions and Ozempic still shows higher average weight loss in trials.

Yes. Both Foundayo and Ozempic require a prescription from a licensed healthcare provider. A consultation is required to assess whether treatment is appropriate for you.

BestGLP1 publishes these guides for informational and comparison purposes only. The information on this site is not medical advice, diagnosis, or treatment, and is not a substitute for guidance from a licensed healthcare professional. GLP-1 medications must be prescribed and monitored by a qualified provider; consult your provider to determine whether treatment is appropriate for your individual circumstances. Prices, side-effect rates, and clinical figures shown here are general references drawn from manufacturer labelling and published trials, and may not reflect your specific situation.

Get started

Find the right
GLP-1 for you

Compare side by side. No signup required.

What's your
target weight?

Let's find your perfect program

Some providers pay BestGLP1 a referral fee when you sign up. We disclose this because the FTC requires it. Our rankings are editorial.